An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo

The use of antibody-based therapy to treat a variety of diseases and conditions is well documented. The use of antibodies as an antidote to treat tetanus infections was one of the first examples of immunotherapy and remains the standard of care for cases involving potential infections. Plasma-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Aliprandini, Eduardo, Takata, Daniela Yumi, Lepique, Ana, Kalil, Jorge, Boscardin, Silvia Beatriz, Moro, Ana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285915/
https://www.ncbi.nlm.nih.gov/pubmed/32550563
http://dx.doi.org/10.1016/j.toxcx.2019.100006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285915/
https://www.ncbi.nlm.nih.gov/pubmed/32550563
http://dx.doi.org/10.1016/j.toxcx.2019.100006

Ejemplares similares